Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET

Clinical trial NCT02231762 · COMPLETED

Trial details

NCT number: NCT02231762
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroenteropancreatic Neuroendocrine Tumors

Start date: 2014-10-01
Primary completion: 2016-12-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.